FDA Approves Once Daily Parkinson’s Pill for Treating Symptoms
In the U.S., over one million people live with Parkinson’s. While there are symptom-treating medications that help tame…
Bridge to Fit: Before you start GLP-1 medications, read this
Now, I’m not a doctor, so I’m not recommending or not recommending weight loss drugs, period. That’s a…
Govt revises essential drug list, adds specialised drugs and medical devices | Patna News
Patna: The health department has revised its Essential Drug List (EDL), adding specialised medicines and medical devices for…
GLP-1 use skyrocketed 24x in a key demographic
This year, the number of US adults on a GLP-1 medication for weight loss reached an astonishing 11%…
Over 112,000 Bottles of Popular Pain Reliever Recalled Nationwide After Consumer Complaints
From fever to headache relief, there’s a good chance you’ve reached for acetaminophen at some point. Most people…
TOI Healing India Forum 2026: Meet the jury shaping India’s wellness conversation
Meet the jury for TOI Healing India Forum 2026 As wellness becomes an increasingly visible part of everyday…
FDA cancels Pune Cipla facility’s drug sale and distribution licences | Mumbai News
Maharashtra Food and Drug Administration has cancelled the drug sale and distribution licences of Cipla Pharma’s warehouse in…
Lilly’s Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLL
INDIANAPOLIS, Oct. 2, 2026 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food…
Daniel Drucker, the Canadian scientist behind Ozempic on why he never gave up
The decades-long journey to discovering the weight-loss drug that changed the world took an unlikely turn in an…
Blood Pressure Medication Recall: Over 25,000 Bottles Affected in 2026
Share on PinterestThe FDA initiated a second recall of its 25 mg chlorthalidone tablets this year, bringing the…
New weight-loss drug targets belly fat and can give ‘flatter stomach’ in weeks
Could a new drug that makes fat cells self-destruct be the next big GLP-1? CBL-514 targets fat cells,…
GLP-1 Weight-Loss Drugs Keep Getting Cheaper: Thank Competition
Thirty years ago, a small startup team of scientists in Boston published findings that began with the venom…